title: [Over-expression of phospholipase D3 inhibits Akt phosphorylation in C2C12 myoblasts].
abstract: Phospholipase D (PLD) hydrolyzes phosphocholine into choline and phosphatide acid, and these metabolites play an important role in regulating cell physiology and biochemistry. To study the biological function of phospholipase D3 (PLD3) during the insulin stimulation in C2C12 myoblasts, we constructed PLD3 over-expressed cell lines (C2C12/pPLD3) and investigated the phosphorylation of Akt. The results showed that the level of phosphorylated Akt (P-Akt) was significantly increased in control C2C12 cells when insulin concentration was elevated during cell treatment, whereas the level of P-Akt in C2C12/pPLD3 cells was not changed. When extending the time of insulin treatment, P-Akt level in C2C12/pPLD3 cells was increased around 2 folds, but the total level of P-Akt in C2C12/pPLD3 was still lower than that in control group. 1-Butanol, a PLD inhibitor, could completely block Akt phosphorylation in C2C12 cells that even stimulated by insulin. However, 1-Butanol did not inhibit the Akt phosphorylation in C2C12/pPLD3 cells, but increased the phosphorylation up to 6 folds higher than control cells. The level of Akt phosphorylation in control C2C12 cells was increased significantly when stimulated by phosphatidic acid (PA), while there was no change in C2C12/pPLD3 cells with the similar treatment. When cells simulated by both PA and insulin, P-Akt level in both C2C12/pPLD3 cells and C2C12 cells were down regulated. Our observations indicated that PLD3 over expression may inhibit Akt phosphorylation and further block the transduction of insulin signaling in C2C12 cells.
authors.affiliation: Shaanxi Center of Stem Cell Engineering and Technology, Shaanxi Key Laboratory of Molecular Biology for Agriculture, College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China.
authors.forename: Junlin
authors.initials: J
authors.lastname: Zhang
authors.forename: Shuai
authors.initials: S
authors.lastname: Chen
authors.forename: Shujin
authors.initials: S
authors.lastname: Zhang
authors.forename: Zhijuan
authors.initials: Z
authors.lastname: Lu
authors.forename: Heping
authors.initials: H
authors.lastname: Yang
authors.forename: Huayan
authors.initials: H
authors.lastname: Wang
mesh_terms: D002460:Cell Line; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D032446:Myoblasts / Q000166:cytology / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D010739:Phospholipase D / Q000096:biosynthesis*; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000737:chemistry* / Q000187:drug effects*; D015398:Signal Transduction; D005090:Exodeoxyribonucleases
chemical_list: D007328:Insulin; D019869:Phosphatidylinositol 3-Kinases; D010739:Phospholipase D; D051057:Proto-Oncogene Proteins c-akt; C586092:PLD3 protein, human; D005090:Exodeoxyribonucleases